nodes	percent_of_prediction	percent_of_DWPC	metapath
Ephedrine—ACHE—Irinotecan—hematologic cancer	0.145	0.346	CbGbCtD
Ephedrine—BCHE—Triamcinolone—hematologic cancer	0.115	0.275	CbGbCtD
Ephedrine—BCHE—Irinotecan—hematologic cancer	0.0875	0.209	CbGbCtD
Ephedrine—BCHE—Cisplatin—hematologic cancer	0.0713	0.17	CbGbCtD
Ephedrine—SLC18A2—hematopoietic system—hematologic cancer	0.00241	0.119	CbGeAlD
Ephedrine—SLC18A2—blood—hematologic cancer	0.0016	0.0786	CbGeAlD
Ephedrine—SLC18A2—lung—hematologic cancer	0.0014	0.0689	CbGeAlD
Ephedrine—ADRA1A—hematopoietic system—hematologic cancer	0.00137	0.0673	CbGeAlD
Ephedrine—ACHE—testis—hematologic cancer	0.00136	0.0667	CbGeAlD
Ephedrine—SLC18A2—testis—hematologic cancer	0.00132	0.065	CbGeAlD
Ephedrine—BCHE—hematopoietic system—hematologic cancer	0.00122	0.0598	CbGeAlD
Ephedrine—SLC6A2—gonad—hematologic cancer	0.00112	0.0551	CbGeAlD
Ephedrine—ACHE—lymph node—hematologic cancer	0.000983	0.0484	CbGeAlD
Ephedrine—Pseudoephedrine—IL2—hematologic cancer	0.000981	0.68	CrCbGaD
Ephedrine—SLC18A2—lymph node—hematologic cancer	0.000958	0.0471	CbGeAlD
Ephedrine—ADRA1A—blood—hematologic cancer	0.000906	0.0446	CbGeAlD
Ephedrine—SLC6A2—lung—hematologic cancer	0.000854	0.0421	CbGeAlD
Ephedrine—SLC6A2—testis—hematologic cancer	0.000806	0.0397	CbGeAlD
Ephedrine—BCHE—blood—hematologic cancer	0.000805	0.0396	CbGeAlD
Ephedrine—BCHE—bone marrow—hematologic cancer	0.000779	0.0384	CbGeAlD
Ephedrine—BCHE—lung—hematologic cancer	0.000706	0.0348	CbGeAlD
Ephedrine—BCHE—testis—hematologic cancer	0.000666	0.0328	CbGeAlD
Ephedrine—SLC6A2—lymph node—hematologic cancer	0.000584	0.0288	CbGeAlD
Ephedrine—BCHE—lymph node—hematologic cancer	0.000483	0.0238	CbGeAlD
Ephedrine—Pseudoephedrine—TNF—hematologic cancer	0.000331	0.229	CrCbGaD
Ephedrine—Dermatitis—Bleomycin—hematologic cancer	0.000222	0.00054	CcSEcCtD
Ephedrine—Asthenia—Carmustine—hematologic cancer	0.000221	0.000537	CcSEcCtD
Ephedrine—Vomiting—Vinorelbine—hematologic cancer	0.000221	0.000536	CcSEcCtD
Ephedrine—Body temperature increased—Gemcitabine—hematologic cancer	0.000221	0.000536	CcSEcCtD
Ephedrine—Dysuria—Epirubicin—hematologic cancer	0.00022	0.000533	CcSEcCtD
Ephedrine—Dizziness—Thiotepa—hematologic cancer	0.000219	0.000533	CcSEcCtD
Ephedrine—Asthenia—Alitretinoin—hematologic cancer	0.000219	0.000532	CcSEcCtD
Ephedrine—Rash—Vinorelbine—hematologic cancer	0.000219	0.000532	CcSEcCtD
Ephedrine—Dermatitis—Vinorelbine—hematologic cancer	0.000219	0.000531	CcSEcCtD
Ephedrine—Headache—Vinorelbine—hematologic cancer	0.000218	0.000528	CcSEcCtD
Ephedrine—Asthenia—Ifosfamide—hematologic cancer	0.000216	0.000526	CcSEcCtD
Ephedrine—Vertigo—Dexamethasone—hematologic cancer	0.000216	0.000524	CcSEcCtD
Ephedrine—Vertigo—Betamethasone—hematologic cancer	0.000216	0.000524	CcSEcCtD
Ephedrine—Arrhythmia—Prednisone—hematologic cancer	0.000215	0.000521	CcSEcCtD
Ephedrine—Sweating—Methotrexate—hematologic cancer	0.000214	0.000521	CcSEcCtD
Ephedrine—Feeling abnormal—Cisplatin—hematologic cancer	0.000214	0.00052	CcSEcCtD
Ephedrine—Insomnia—Prednisolone—hematologic cancer	0.000213	0.000516	CcSEcCtD
Ephedrine—Dyspnoea—Etoposide—hematologic cancer	0.000212	0.000516	CcSEcCtD
Ephedrine—Dizziness—Thalidomide—hematologic cancer	0.000212	0.000515	CcSEcCtD
Ephedrine—Angina pectoris—Doxorubicin—hematologic cancer	0.000212	0.000514	CcSEcCtD
Ephedrine—Nausea—Bortezomib—hematologic cancer	0.000211	0.000513	CcSEcCtD
Ephedrine—Asthenia—Vincristine—hematologic cancer	0.000211	0.000512	CcSEcCtD
Ephedrine—Tachycardia—Triamcinolone—hematologic cancer	0.000211	0.000512	CcSEcCtD
Ephedrine—Vomiting—Thiotepa—hematologic cancer	0.000211	0.000512	CcSEcCtD
Ephedrine—Nausea—Bleomycin—hematologic cancer	0.00021	0.000509	CcSEcCtD
Ephedrine—Rash—Thiotepa—hematologic cancer	0.000209	0.000508	CcSEcCtD
Ephedrine—Dermatitis—Thiotepa—hematologic cancer	0.000209	0.000507	CcSEcCtD
Ephedrine—Hyperhidrosis—Triamcinolone—hematologic cancer	0.000209	0.000507	CcSEcCtD
Ephedrine—Headache—Thiotepa—hematologic cancer	0.000208	0.000505	CcSEcCtD
Ephedrine—Hypertension—Dexamethasone—hematologic cancer	0.000207	0.000504	CcSEcCtD
Ephedrine—Hypertension—Betamethasone—hematologic cancer	0.000207	0.000504	CcSEcCtD
Ephedrine—Decreased appetite—Etoposide—hematologic cancer	0.000207	0.000503	CcSEcCtD
Ephedrine—Nausea—Vinorelbine—hematologic cancer	0.000206	0.000501	CcSEcCtD
Ephedrine—Body temperature increased—Cisplatin—hematologic cancer	0.000206	0.000499	CcSEcCtD
Ephedrine—Asthenia—Irinotecan—hematologic cancer	0.000205	0.000499	CcSEcCtD
Ephedrine—Asthenia—Mitoxantrone—hematologic cancer	0.000205	0.000499	CcSEcCtD
Ephedrine—Vomiting—Thalidomide—hematologic cancer	0.000204	0.000495	CcSEcCtD
Ephedrine—Anxiety—Dexamethasone—hematologic cancer	0.000204	0.000495	CcSEcCtD
Ephedrine—Anxiety—Betamethasone—hematologic cancer	0.000204	0.000495	CcSEcCtD
Ephedrine—Dizziness—Carmustine—hematologic cancer	0.000204	0.000495	CcSEcCtD
Ephedrine—Pain—Etoposide—hematologic cancer	0.000204	0.000495	CcSEcCtD
Ephedrine—Dysuria—Doxorubicin—hematologic cancer	0.000203	0.000493	CcSEcCtD
Ephedrine—Rash—Thalidomide—hematologic cancer	0.000202	0.000491	CcSEcCtD
Ephedrine—Dermatitis—Thalidomide—hematologic cancer	0.000202	0.000491	CcSEcCtD
Ephedrine—Dizziness—Alitretinoin—hematologic cancer	0.000202	0.00049	CcSEcCtD
Ephedrine—Headache—Thalidomide—hematologic cancer	0.000201	0.000488	CcSEcCtD
Ephedrine—Pain—Prednisolone—hematologic cancer	0.000201	0.000488	CcSEcCtD
Ephedrine—Sweating—Epirubicin—hematologic cancer	0.000201	0.000487	CcSEcCtD
Ephedrine—Asthenia—Gemcitabine—hematologic cancer	0.0002	0.000486	CcSEcCtD
Ephedrine—Dizziness—Ifosfamide—hematologic cancer	0.000199	0.000484	CcSEcCtD
Ephedrine—Nausea—Thiotepa—hematologic cancer	0.000197	0.000478	CcSEcCtD
Ephedrine—Feeling abnormal—Etoposide—hematologic cancer	0.000196	0.000477	CcSEcCtD
Ephedrine—Vomiting—Carmustine—hematologic cancer	0.000196	0.000476	CcSEcCtD
Ephedrine—Insomnia—Triamcinolone—hematologic cancer	0.000195	0.000475	CcSEcCtD
Ephedrine—Dizziness—Vincristine—hematologic cancer	0.000194	0.000472	CcSEcCtD
Ephedrine—Rash—Carmustine—hematologic cancer	0.000194	0.000472	CcSEcCtD
Ephedrine—Dermatitis—Carmustine—hematologic cancer	0.000194	0.000471	CcSEcCtD
Ephedrine—Vomiting—Alitretinoin—hematologic cancer	0.000194	0.000471	CcSEcCtD
Ephedrine—Feeling abnormal—Prednisolone—hematologic cancer	0.000194	0.00047	CcSEcCtD
Ephedrine—Headache—Carmustine—hematologic cancer	0.000193	0.000469	CcSEcCtD
Ephedrine—Dyspnoea—Triamcinolone—hematologic cancer	0.000193	0.000468	CcSEcCtD
Ephedrine—Rash—Alitretinoin—hematologic cancer	0.000192	0.000467	CcSEcCtD
Ephedrine—Agitation—Prednisone—hematologic cancer	0.000192	0.000467	CcSEcCtD
Ephedrine—Dermatitis—Alitretinoin—hematologic cancer	0.000192	0.000467	CcSEcCtD
Ephedrine—Vomiting—Ifosfamide—hematologic cancer	0.000192	0.000466	CcSEcCtD
Ephedrine—Tachycardia—Betamethasone—hematologic cancer	0.000191	0.000465	CcSEcCtD
Ephedrine—Tachycardia—Dexamethasone—hematologic cancer	0.000191	0.000465	CcSEcCtD
Ephedrine—Bradycardia—Epirubicin—hematologic cancer	0.000191	0.000465	CcSEcCtD
Ephedrine—Headache—Alitretinoin—hematologic cancer	0.000191	0.000464	CcSEcCtD
Ephedrine—Nausea—Thalidomide—hematologic cancer	0.000191	0.000463	CcSEcCtD
Ephedrine—Dyspepsia—Triamcinolone—hematologic cancer	0.00019	0.000462	CcSEcCtD
Ephedrine—Rash—Ifosfamide—hematologic cancer	0.00019	0.000462	CcSEcCtD
Ephedrine—Dermatitis—Ifosfamide—hematologic cancer	0.00019	0.000461	CcSEcCtD
Ephedrine—Hyperhidrosis—Dexamethasone—hematologic cancer	0.00019	0.00046	CcSEcCtD
Ephedrine—Hyperhidrosis—Betamethasone—hematologic cancer	0.00019	0.00046	CcSEcCtD
Ephedrine—Dizziness—Irinotecan—hematologic cancer	0.000189	0.00046	CcSEcCtD
Ephedrine—Body temperature increased—Etoposide—hematologic cancer	0.000188	0.000457	CcSEcCtD
Ephedrine—Vertigo—Prednisone—hematologic cancer	0.000188	0.000456	CcSEcCtD
Ephedrine—Vomiting—Vincristine—hematologic cancer	0.000187	0.000454	CcSEcCtD
Ephedrine—Anorexia—Dexamethasone—hematologic cancer	0.000187	0.000454	CcSEcCtD
Ephedrine—Anorexia—Betamethasone—hematologic cancer	0.000187	0.000454	CcSEcCtD
Ephedrine—Asthenia—Cisplatin—hematologic cancer	0.000187	0.000453	CcSEcCtD
Ephedrine—Sweating—Doxorubicin—hematologic cancer	0.000186	0.000451	CcSEcCtD
Ephedrine—Rash—Vincristine—hematologic cancer	0.000185	0.00045	CcSEcCtD
Ephedrine—Dermatitis—Vincristine—hematologic cancer	0.000185	0.00045	CcSEcCtD
Ephedrine—Pain—Triamcinolone—hematologic cancer	0.000185	0.000449	CcSEcCtD
Ephedrine—Headache—Vincristine—hematologic cancer	0.000184	0.000447	CcSEcCtD
Ephedrine—Nausea—Carmustine—hematologic cancer	0.000183	0.000444	CcSEcCtD
Ephedrine—Vomiting—Irinotecan—hematologic cancer	0.000182	0.000442	CcSEcCtD
Ephedrine—Vomiting—Mitoxantrone—hematologic cancer	0.000182	0.000442	CcSEcCtD
Ephedrine—Nausea—Alitretinoin—hematologic cancer	0.000181	0.00044	CcSEcCtD
Ephedrine—Hypertension—Prednisone—hematologic cancer	0.000181	0.000439	CcSEcCtD
Ephedrine—Rash—Irinotecan—hematologic cancer	0.000181	0.000439	CcSEcCtD
Ephedrine—Rash—Mitoxantrone—hematologic cancer	0.000181	0.000439	CcSEcCtD
Ephedrine—Dermatitis—Mitoxantrone—hematologic cancer	0.00018	0.000438	CcSEcCtD
Ephedrine—Dermatitis—Irinotecan—hematologic cancer	0.00018	0.000438	CcSEcCtD
Ephedrine—Headache—Mitoxantrone—hematologic cancer	0.000179	0.000436	CcSEcCtD
Ephedrine—Headache—Irinotecan—hematologic cancer	0.000179	0.000436	CcSEcCtD
Ephedrine—Nausea—Ifosfamide—hematologic cancer	0.000179	0.000435	CcSEcCtD
Ephedrine—Feeling abnormal—Triamcinolone—hematologic cancer	0.000178	0.000432	CcSEcCtD
Ephedrine—Anxiety—Prednisone—hematologic cancer	0.000177	0.000431	CcSEcCtD
Ephedrine—Vomiting—Gemcitabine—hematologic cancer	0.000177	0.000431	CcSEcCtD
Ephedrine—Insomnia—Betamethasone—hematologic cancer	0.000177	0.000431	CcSEcCtD
Ephedrine—Insomnia—Dexamethasone—hematologic cancer	0.000177	0.000431	CcSEcCtD
Ephedrine—Bradycardia—Doxorubicin—hematologic cancer	0.000177	0.00043	CcSEcCtD
Ephedrine—Rash—Gemcitabine—hematologic cancer	0.000176	0.000427	CcSEcCtD
Ephedrine—Dermatitis—Gemcitabine—hematologic cancer	0.000176	0.000427	CcSEcCtD
Ephedrine—Headache—Gemcitabine—hematologic cancer	0.000175	0.000424	CcSEcCtD
Ephedrine—Nausea—Vincristine—hematologic cancer	0.000175	0.000424	CcSEcCtD
Ephedrine—Dyspepsia—Betamethasone—hematologic cancer	0.000173	0.000419	CcSEcCtD
Ephedrine—Dyspepsia—Dexamethasone—hematologic cancer	0.000173	0.000419	CcSEcCtD
Ephedrine—Asthenia—Etoposide—hematologic cancer	0.000171	0.000415	CcSEcCtD
Ephedrine—Body temperature increased—Triamcinolone—hematologic cancer	0.000171	0.000415	CcSEcCtD
Ephedrine—Decreased appetite—Betamethasone—hematologic cancer	0.00017	0.000414	CcSEcCtD
Ephedrine—Decreased appetite—Dexamethasone—hematologic cancer	0.00017	0.000414	CcSEcCtD
Ephedrine—Nausea—Irinotecan—hematologic cancer	0.00017	0.000413	CcSEcCtD
Ephedrine—Nausea—Mitoxantrone—hematologic cancer	0.00017	0.000413	CcSEcCtD
Ephedrine—Arrhythmia—Epirubicin—hematologic cancer	0.000168	0.000408	CcSEcCtD
Ephedrine—Pain—Dexamethasone—hematologic cancer	0.000168	0.000407	CcSEcCtD
Ephedrine—Pain—Betamethasone—hematologic cancer	0.000168	0.000407	CcSEcCtD
Ephedrine—Tachycardia—Prednisone—hematologic cancer	0.000167	0.000405	CcSEcCtD
Ephedrine—Nausea—Gemcitabine—hematologic cancer	0.000166	0.000402	CcSEcCtD
Ephedrine—Vomiting—Cisplatin—hematologic cancer	0.000165	0.000402	CcSEcCtD
Ephedrine—Hyperhidrosis—Prednisone—hematologic cancer	0.000165	0.000401	CcSEcCtD
Ephedrine—Rash—Cisplatin—hematologic cancer	0.000164	0.000398	CcSEcCtD
Ephedrine—Dermatitis—Cisplatin—hematologic cancer	0.000164	0.000398	CcSEcCtD
Ephedrine—Anorexia—Prednisone—hematologic cancer	0.000163	0.000395	CcSEcCtD
Ephedrine—Feeling abnormal—Dexamethasone—hematologic cancer	0.000162	0.000392	CcSEcCtD
Ephedrine—Feeling abnormal—Betamethasone—hematologic cancer	0.000162	0.000392	CcSEcCtD
Ephedrine—Tension—Epirubicin—hematologic cancer	0.000161	0.00039	CcSEcCtD
Ephedrine—Nervousness—Epirubicin—hematologic cancer	0.000159	0.000386	CcSEcCtD
Ephedrine—Dizziness—Etoposide—hematologic cancer	0.000158	0.000383	CcSEcCtD
Ephedrine—Muscle spasms—Epirubicin—hematologic cancer	0.000157	0.000382	CcSEcCtD
Ephedrine—Vertigo—Methotrexate—hematologic cancer	0.000157	0.000381	CcSEcCtD
Ephedrine—Dizziness—Prednisolone—hematologic cancer	0.000155	0.000377	CcSEcCtD
Ephedrine—Arrhythmia—Doxorubicin—hematologic cancer	0.000155	0.000377	CcSEcCtD
Ephedrine—Asthenia—Triamcinolone—hematologic cancer	0.000155	0.000376	CcSEcCtD
Ephedrine—Body temperature increased—Betamethasone—hematologic cancer	0.000155	0.000376	CcSEcCtD
Ephedrine—Body temperature increased—Dexamethasone—hematologic cancer	0.000155	0.000376	CcSEcCtD
Ephedrine—Nausea—Cisplatin—hematologic cancer	0.000154	0.000375	CcSEcCtD
Ephedrine—Insomnia—Prednisone—hematologic cancer	0.000154	0.000375	CcSEcCtD
Ephedrine—Vomiting—Etoposide—hematologic cancer	0.000151	0.000368	CcSEcCtD
Ephedrine—Agitation—Epirubicin—hematologic cancer	0.00015	0.000365	CcSEcCtD
Ephedrine—Dyspepsia—Prednisone—hematologic cancer	0.00015	0.000365	CcSEcCtD
Ephedrine—Rash—Etoposide—hematologic cancer	0.00015	0.000365	CcSEcCtD
Ephedrine—Dermatitis—Etoposide—hematologic cancer	0.00015	0.000364	CcSEcCtD
Ephedrine—Headache—Etoposide—hematologic cancer	0.000149	0.000362	CcSEcCtD
Ephedrine—Chest pain—Methotrexate—hematologic cancer	0.000149	0.000361	CcSEcCtD
Ephedrine—Tension—Doxorubicin—hematologic cancer	0.000149	0.000361	CcSEcCtD
Ephedrine—Decreased appetite—Prednisone—hematologic cancer	0.000148	0.00036	CcSEcCtD
Ephedrine—Rash—Prednisolone—hematologic cancer	0.000148	0.00036	CcSEcCtD
Ephedrine—Dermatitis—Prednisolone—hematologic cancer	0.000148	0.000359	CcSEcCtD
Ephedrine—Headache—Prednisolone—hematologic cancer	0.000147	0.000357	CcSEcCtD
Ephedrine—Nervousness—Doxorubicin—hematologic cancer	0.000147	0.000357	CcSEcCtD
Ephedrine—Vertigo—Epirubicin—hematologic cancer	0.000147	0.000357	CcSEcCtD
Ephedrine—Muscle spasms—Doxorubicin—hematologic cancer	0.000146	0.000353	CcSEcCtD
Ephedrine—Palpitations—Epirubicin—hematologic cancer	0.000145	0.000351	CcSEcCtD
Ephedrine—Confusional state—Methotrexate—hematologic cancer	0.000144	0.000349	CcSEcCtD
Ephedrine—Dizziness—Triamcinolone—hematologic cancer	0.000143	0.000347	CcSEcCtD
Ephedrine—Nausea—Etoposide—hematologic cancer	0.000141	0.000344	CcSEcCtD
Ephedrine—Hypertension—Epirubicin—hematologic cancer	0.000141	0.000343	CcSEcCtD
Ephedrine—Feeling abnormal—Prednisone—hematologic cancer	0.000141	0.000342	CcSEcCtD
Ephedrine—Asthenia—Dexamethasone—hematologic cancer	0.000141	0.000342	CcSEcCtD
Ephedrine—Asthenia—Betamethasone—hematologic cancer	0.000141	0.000342	CcSEcCtD
Ephedrine—Nausea—Prednisolone—hematologic cancer	0.00014	0.000339	CcSEcCtD
Ephedrine—Chest pain—Epirubicin—hematologic cancer	0.000139	0.000338	CcSEcCtD
Ephedrine—Agitation—Doxorubicin—hematologic cancer	0.000139	0.000338	CcSEcCtD
Ephedrine—Anxiety—Epirubicin—hematologic cancer	0.000139	0.000337	CcSEcCtD
Ephedrine—Hyperhidrosis—Methotrexate—hematologic cancer	0.000138	0.000335	CcSEcCtD
Ephedrine—Vomiting—Triamcinolone—hematologic cancer	0.000137	0.000334	CcSEcCtD
Ephedrine—Rash—Triamcinolone—hematologic cancer	0.000136	0.000331	CcSEcCtD
Ephedrine—Dermatitis—Triamcinolone—hematologic cancer	0.000136	0.000331	CcSEcCtD
Ephedrine—Vertigo—Doxorubicin—hematologic cancer	0.000136	0.00033	CcSEcCtD
Ephedrine—Anorexia—Methotrexate—hematologic cancer	0.000136	0.00033	CcSEcCtD
Ephedrine—Headache—Triamcinolone—hematologic cancer	0.000135	0.000329	CcSEcCtD
Ephedrine—Body temperature increased—Prednisone—hematologic cancer	0.000135	0.000328	CcSEcCtD
Ephedrine—Confusional state—Epirubicin—hematologic cancer	0.000135	0.000327	CcSEcCtD
Ephedrine—Palpitations—Doxorubicin—hematologic cancer	0.000134	0.000325	CcSEcCtD
Ephedrine—Hypertension—Doxorubicin—hematologic cancer	0.000131	0.000317	CcSEcCtD
Ephedrine—Selegiline—ABCB1—hematologic cancer	0.000131	0.0905	CrCbGaD
Ephedrine—Tachycardia—Epirubicin—hematologic cancer	0.00013	0.000316	CcSEcCtD
Ephedrine—Dizziness—Dexamethasone—hematologic cancer	0.00013	0.000315	CcSEcCtD
Ephedrine—Dizziness—Betamethasone—hematologic cancer	0.00013	0.000315	CcSEcCtD
Ephedrine—Hyperhidrosis—Epirubicin—hematologic cancer	0.000129	0.000313	CcSEcCtD
Ephedrine—Insomnia—Methotrexate—hematologic cancer	0.000129	0.000313	CcSEcCtD
Ephedrine—Chest pain—Doxorubicin—hematologic cancer	0.000129	0.000313	CcSEcCtD
Ephedrine—Anxiety—Doxorubicin—hematologic cancer	0.000128	0.000312	CcSEcCtD
Ephedrine—Nausea—Triamcinolone—hematologic cancer	0.000128	0.000312	CcSEcCtD
Ephedrine—Anorexia—Epirubicin—hematologic cancer	0.000127	0.000309	CcSEcCtD
Ephedrine—Dyspnoea—Methotrexate—hematologic cancer	0.000127	0.000309	CcSEcCtD
Ephedrine—Dyspepsia—Methotrexate—hematologic cancer	0.000126	0.000305	CcSEcCtD
Ephedrine—Vomiting—Dexamethasone—hematologic cancer	0.000125	0.000303	CcSEcCtD
Ephedrine—Vomiting—Betamethasone—hematologic cancer	0.000125	0.000303	CcSEcCtD
Ephedrine—Confusional state—Doxorubicin—hematologic cancer	0.000125	0.000303	CcSEcCtD
Ephedrine—Decreased appetite—Methotrexate—hematologic cancer	0.000124	0.000301	CcSEcCtD
Ephedrine—Rash—Dexamethasone—hematologic cancer	0.000124	0.0003	CcSEcCtD
Ephedrine—Rash—Betamethasone—hematologic cancer	0.000124	0.0003	CcSEcCtD
Ephedrine—Dermatitis—Betamethasone—hematologic cancer	0.000123	0.0003	CcSEcCtD
Ephedrine—Dermatitis—Dexamethasone—hematologic cancer	0.000123	0.0003	CcSEcCtD
Ephedrine—Headache—Dexamethasone—hematologic cancer	0.000123	0.000298	CcSEcCtD
Ephedrine—Headache—Betamethasone—hematologic cancer	0.000123	0.000298	CcSEcCtD
Ephedrine—Asthenia—Prednisone—hematologic cancer	0.000122	0.000297	CcSEcCtD
Ephedrine—Pain—Methotrexate—hematologic cancer	0.000122	0.000296	CcSEcCtD
Ephedrine—Insomnia—Epirubicin—hematologic cancer	0.000121	0.000293	CcSEcCtD
Ephedrine—Tachycardia—Doxorubicin—hematologic cancer	0.000121	0.000293	CcSEcCtD
Ephedrine—Hyperhidrosis—Doxorubicin—hematologic cancer	0.000119	0.00029	CcSEcCtD
Ephedrine—Dyspnoea—Epirubicin—hematologic cancer	0.000119	0.000289	CcSEcCtD
Ephedrine—Anorexia—Doxorubicin—hematologic cancer	0.000118	0.000286	CcSEcCtD
Ephedrine—Feeling abnormal—Methotrexate—hematologic cancer	0.000118	0.000286	CcSEcCtD
Ephedrine—Dyspepsia—Epirubicin—hematologic cancer	0.000118	0.000285	CcSEcCtD
Ephedrine—Nausea—Betamethasone—hematologic cancer	0.000116	0.000283	CcSEcCtD
Ephedrine—Nausea—Dexamethasone—hematologic cancer	0.000116	0.000283	CcSEcCtD
Ephedrine—Decreased appetite—Epirubicin—hematologic cancer	0.000116	0.000282	CcSEcCtD
Ephedrine—Pain—Epirubicin—hematologic cancer	0.000114	0.000277	CcSEcCtD
Ephedrine—Dizziness—Prednisone—hematologic cancer	0.000113	0.000274	CcSEcCtD
Ephedrine—Body temperature increased—Methotrexate—hematologic cancer	0.000113	0.000274	CcSEcCtD
Ephedrine—Insomnia—Doxorubicin—hematologic cancer	0.000112	0.000271	CcSEcCtD
Ephedrine—Dyspnoea—Doxorubicin—hematologic cancer	0.00011	0.000268	CcSEcCtD
Ephedrine—Feeling abnormal—Epirubicin—hematologic cancer	0.00011	0.000267	CcSEcCtD
Ephedrine—Dyspepsia—Doxorubicin—hematologic cancer	0.000109	0.000264	CcSEcCtD
Ephedrine—Vomiting—Prednisone—hematologic cancer	0.000109	0.000264	CcSEcCtD
Ephedrine—Rash—Prednisone—hematologic cancer	0.000108	0.000261	CcSEcCtD
Ephedrine—Dermatitis—Prednisone—hematologic cancer	0.000108	0.000261	CcSEcCtD
Ephedrine—Decreased appetite—Doxorubicin—hematologic cancer	0.000107	0.000261	CcSEcCtD
Ephedrine—Headache—Prednisone—hematologic cancer	0.000107	0.00026	CcSEcCtD
Ephedrine—Pain—Doxorubicin—hematologic cancer	0.000106	0.000257	CcSEcCtD
Ephedrine—Body temperature increased—Epirubicin—hematologic cancer	0.000106	0.000256	CcSEcCtD
Ephedrine—Asthenia—Methotrexate—hematologic cancer	0.000102	0.000249	CcSEcCtD
Ephedrine—Feeling abnormal—Doxorubicin—hematologic cancer	0.000102	0.000247	CcSEcCtD
Ephedrine—Nausea—Prednisone—hematologic cancer	0.000101	0.000246	CcSEcCtD
Ephedrine—Body temperature increased—Doxorubicin—hematologic cancer	9.77e-05	0.000237	CcSEcCtD
Ephedrine—Asthenia—Epirubicin—hematologic cancer	9.58e-05	0.000233	CcSEcCtD
Ephedrine—Dizziness—Methotrexate—hematologic cancer	9.44e-05	0.000229	CcSEcCtD
Ephedrine—Vomiting—Methotrexate—hematologic cancer	9.07e-05	0.00022	CcSEcCtD
Ephedrine—Rash—Methotrexate—hematologic cancer	9e-05	0.000218	CcSEcCtD
Ephedrine—Dermatitis—Methotrexate—hematologic cancer	8.99e-05	0.000218	CcSEcCtD
Ephedrine—Headache—Methotrexate—hematologic cancer	8.94e-05	0.000217	CcSEcCtD
Ephedrine—Asthenia—Doxorubicin—hematologic cancer	8.86e-05	0.000215	CcSEcCtD
Ephedrine—Dizziness—Epirubicin—hematologic cancer	8.83e-05	0.000214	CcSEcCtD
Ephedrine—Vomiting—Epirubicin—hematologic cancer	8.49e-05	0.000206	CcSEcCtD
Ephedrine—Nausea—Methotrexate—hematologic cancer	8.48e-05	0.000206	CcSEcCtD
Ephedrine—Rash—Epirubicin—hematologic cancer	8.42e-05	0.000204	CcSEcCtD
Ephedrine—Dermatitis—Epirubicin—hematologic cancer	8.41e-05	0.000204	CcSEcCtD
Ephedrine—Headache—Epirubicin—hematologic cancer	8.37e-05	0.000203	CcSEcCtD
Ephedrine—Dizziness—Doxorubicin—hematologic cancer	8.17e-05	0.000198	CcSEcCtD
Ephedrine—Nausea—Epirubicin—hematologic cancer	7.93e-05	0.000193	CcSEcCtD
Ephedrine—Vomiting—Doxorubicin—hematologic cancer	7.86e-05	0.000191	CcSEcCtD
Ephedrine—Rash—Doxorubicin—hematologic cancer	7.79e-05	0.000189	CcSEcCtD
Ephedrine—Dermatitis—Doxorubicin—hematologic cancer	7.78e-05	0.000189	CcSEcCtD
Ephedrine—Headache—Doxorubicin—hematologic cancer	7.74e-05	0.000188	CcSEcCtD
Ephedrine—Nausea—Doxorubicin—hematologic cancer	7.34e-05	0.000178	CcSEcCtD
Ephedrine—ADRB2—GPCR downstream signaling—PIK3CG—hematologic cancer	2.45e-05	0.000166	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—IL2RA—hematologic cancer	2.43e-05	0.000165	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.42e-05	0.000165	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PARP1—hematologic cancer	2.42e-05	0.000164	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—XIAP—hematologic cancer	2.41e-05	0.000164	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—FBXW7—hematologic cancer	2.38e-05	0.000162	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—ABCB1—hematologic cancer	2.37e-05	0.000161	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—JAK1—hematologic cancer	2.36e-05	0.000161	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PRKCG—hematologic cancer	2.36e-05	0.000161	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—SH2B3—hematologic cancer	2.35e-05	0.00016	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—SMARCA4—hematologic cancer	2.35e-05	0.00016	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—GZMB—hematologic cancer	2.34e-05	0.000159	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—HDAC2—hematologic cancer	2.33e-05	0.000159	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CXCR4—hematologic cancer	2.33e-05	0.000159	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—GSTM1—hematologic cancer	2.3e-05	0.000157	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—NCOR1—hematologic cancer	2.3e-05	0.000157	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CTNNA1—hematologic cancer	2.28e-05	0.000155	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—MTHFR—hematologic cancer	2.28e-05	0.000155	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CBL—hematologic cancer	2.27e-05	0.000155	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—EIF4EBP1—hematologic cancer	2.27e-05	0.000154	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—HSPB1—hematologic cancer	2.27e-05	0.000154	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CCL3—hematologic cancer	2.27e-05	0.000154	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IL3—hematologic cancer	2.25e-05	0.000153	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PTHLH—hematologic cancer	2.24e-05	0.000153	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—SDC1—hematologic cancer	2.24e-05	0.000153	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PIK3CG—hematologic cancer	2.22e-05	0.000151	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PTPN1—hematologic cancer	2.21e-05	0.00015	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—IL2RA—hematologic cancer	2.2e-05	0.00015	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PTGER4—hematologic cancer	2.18e-05	0.000149	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PTPN11—hematologic cancer	2.18e-05	0.000148	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—RASGRP1—hematologic cancer	2.17e-05	0.000148	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—LCK—hematologic cancer	2.17e-05	0.000148	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—HSP90AA1—hematologic cancer	2.17e-05	0.000148	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—SYK—hematologic cancer	2.17e-05	0.000148	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—PIK3CD—hematologic cancer	2.15e-05	0.000146	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—H3F3A—hematologic cancer	2.13e-05	0.000145	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—CREB1—hematologic cancer	2.11e-05	0.000144	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—STAT1—hematologic cancer	2.09e-05	0.000142	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PRKCZ—hematologic cancer	2.07e-05	0.000141	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—CCL2—hematologic cancer	2.07e-05	0.000141	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—IL6R—hematologic cancer	2.06e-05	0.00014	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—MTHFR—hematologic cancer	2.03e-05	0.000138	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—PIK3R1—hematologic cancer	2.03e-05	0.000138	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—PIK3CG—hematologic cancer	2.02e-05	0.000138	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.01e-05	0.000137	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PARP1—hematologic cancer	2e-05	0.000136	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—JAK2—hematologic cancer	1.97e-05	0.000134	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—FBXW7—hematologic cancer	1.97e-05	0.000134	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—MAP2K1—hematologic cancer	1.97e-05	0.000134	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—GRB2—hematologic cancer	1.95e-05	0.000133	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PIK3CD—hematologic cancer	1.95e-05	0.000133	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PDGFA—hematologic cancer	1.95e-05	0.000133	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CXCR4—hematologic cancer	1.93e-05	0.000131	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—HDAC2—hematologic cancer	1.93e-05	0.000131	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—KITLG—hematologic cancer	1.92e-05	0.000131	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PIK3CG—hematologic cancer	1.92e-05	0.00013	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CBL—hematologic cancer	1.88e-05	0.000128	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—STAT5A—hematologic cancer	1.88e-05	0.000128	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—PIK3CB—hematologic cancer	1.87e-05	0.000128	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CDKN2B—hematologic cancer	1.86e-05	0.000127	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IL3—hematologic cancer	1.86e-05	0.000127	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PIK3R1—hematologic cancer	1.84e-05	0.000125	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PIK3CG—hematologic cancer	1.84e-05	0.000125	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PTPN1—hematologic cancer	1.83e-05	0.000124	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PTPN11—hematologic cancer	1.8e-05	0.000123	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CD86—hematologic cancer	1.8e-05	0.000123	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—RASGRP1—hematologic cancer	1.8e-05	0.000122	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—SYK—hematologic cancer	1.79e-05	0.000122	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—HSP90AA1—hematologic cancer	1.79e-05	0.000122	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.79e-05	0.000122	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—JAK2—hematologic cancer	1.79e-05	0.000122	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—PIK3CD—hematologic cancer	1.78e-05	0.000121	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—HES1—hematologic cancer	1.78e-05	0.000121	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—CREBBP—hematologic cancer	1.78e-05	0.000121	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—NCOR1—hematologic cancer	1.77e-05	0.00012	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—CREB1—hematologic cancer	1.75e-05	0.000119	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CSF2—hematologic cancer	1.75e-05	0.000119	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—FGF1—hematologic cancer	1.75e-05	0.000119	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—STAT1—hematologic cancer	1.73e-05	0.000118	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—FOXO1—hematologic cancer	1.72e-05	0.000117	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—IL2—hematologic cancer	1.72e-05	0.000117	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PDGFRB—hematologic cancer	1.72e-05	0.000117	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—CCL2—hematologic cancer	1.71e-05	0.000116	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PIK3CG—hematologic cancer	1.71e-05	0.000116	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—IL6R—hematologic cancer	1.71e-05	0.000116	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PIK3CB—hematologic cancer	1.7e-05	0.000116	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PDGFRA—hematologic cancer	1.69e-05	0.000115	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—JAK1—hematologic cancer	1.69e-05	0.000115	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PRKCG—hematologic cancer	1.69e-05	0.000115	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PIK3CD—hematologic cancer	1.68e-05	0.000115	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—PIK3R1—hematologic cancer	1.68e-05	0.000114	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—ALB—hematologic cancer	1.66e-05	0.000113	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—JAK2—hematologic cancer	1.63e-05	0.000111	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—MAP2K1—hematologic cancer	1.63e-05	0.000111	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—GRB2—hematologic cancer	1.62e-05	0.00011	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PIK3CD—hematologic cancer	1.61e-05	0.00011	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PDGFA—hematologic cancer	1.61e-05	0.00011	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—KITLG—hematologic cancer	1.59e-05	0.000108	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PIK3R1—hematologic cancer	1.59e-05	0.000108	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—CREBBP—hematologic cancer	1.58e-05	0.000108	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IL2RA—hematologic cancer	1.57e-05	0.000107	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—IL2—hematologic cancer	1.56e-05	0.000106	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—TERT—hematologic cancer	1.56e-05	0.000106	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—STAT5A—hematologic cancer	1.55e-05	0.000106	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—PIK3CB—hematologic cancer	1.55e-05	0.000105	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CDKN2B—hematologic cancer	1.54e-05	0.000105	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PIK3R1—hematologic cancer	1.52e-05	0.000104	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PDGFB—hematologic cancer	1.52e-05	0.000103	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PIK3CD—hematologic cancer	1.5e-05	0.000102	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CD86—hematologic cancer	1.49e-05	0.000101	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—TSC2—hematologic cancer	1.49e-05	0.000101	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—ALB—hematologic cancer	1.48e-05	0.000101	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—JAK2—hematologic cancer	1.48e-05	0.000101	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—HES1—hematologic cancer	1.47e-05	0.0001	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PIK3CB—hematologic cancer	1.47e-05	9.99e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—NCOR1—hematologic cancer	1.46e-05	9.95e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CSF2—hematologic cancer	1.44e-05	9.83e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—FGF1—hematologic cancer	1.44e-05	9.83e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—FGFR3—hematologic cancer	1.43e-05	9.72e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—FOXO1—hematologic cancer	1.42e-05	9.69e-05	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—IL2—hematologic cancer	1.42e-05	9.69e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PDGFRB—hematologic cancer	1.42e-05	9.67e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PIK3R1—hematologic cancer	1.42e-05	9.65e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MAPK14—hematologic cancer	1.41e-05	9.63e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PIK3CB—hematologic cancer	1.41e-05	9.58e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PDGFRA—hematologic cancer	1.4e-05	9.52e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—JAK1—hematologic cancer	1.39e-05	9.49e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PRKCG—hematologic cancer	1.39e-05	9.49e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—ESR1—hematologic cancer	1.39e-05	9.45e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—FN1—hematologic cancer	1.37e-05	9.33e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—NFKBIA—hematologic cancer	1.35e-05	9.22e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—BAD—hematologic cancer	1.35e-05	9.22e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—NOTCH1—hematologic cancer	1.34e-05	9.13e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CD80—hematologic cancer	1.31e-05	8.94e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—KIT—hematologic cancer	1.31e-05	8.93e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PIK3CG—hematologic cancer	1.31e-05	8.93e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—NRAS—hematologic cancer	1.31e-05	8.93e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PIK3CB—hematologic cancer	1.31e-05	8.91e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IL2RA—hematologic cancer	1.3e-05	8.86e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—IL2—hematologic cancer	1.29e-05	8.8e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PTPN11—hematologic cancer	1.29e-05	8.77e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—TERT—hematologic cancer	1.29e-05	8.77e-05	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PTEN—hematologic cancer	1.27e-05	8.63e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PDGFB—hematologic cancer	1.26e-05	8.56e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—MAPK3—hematologic cancer	1.26e-05	8.55e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CREB1—hematologic cancer	1.25e-05	8.5e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—BRAF—hematologic cancer	1.23e-05	8.39e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—TSC2—hematologic cancer	1.23e-05	8.36e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CCL2—hematologic cancer	1.22e-05	8.32e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IL6R—hematologic cancer	1.22e-05	8.29e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CREBBP—hematologic cancer	1.22e-05	8.28e-05	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—EP300—hematologic cancer	1.21e-05	8.23e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—FGFR3—hematologic cancer	1.18e-05	8.04e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MAPK14—hematologic cancer	1.17e-05	7.96e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MAP2K1—hematologic cancer	1.16e-05	7.9e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PIK3CD—hematologic cancer	1.15e-05	7.85e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—ESR1—hematologic cancer	1.15e-05	7.81e-05	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—PIK3CA—hematologic cancer	1.14e-05	7.77e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—FN1—hematologic cancer	1.13e-05	7.72e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PTEN—hematologic cancer	1.13e-05	7.7e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—KRAS—hematologic cancer	1.13e-05	7.68e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—BAD—hematologic cancer	1.12e-05	7.63e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—NFKBIA—hematologic cancer	1.12e-05	7.63e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—NOTCH1—hematologic cancer	1.11e-05	7.55e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—FGF2—hematologic cancer	1.1e-05	7.52e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PIK3R1—hematologic cancer	1.09e-05	7.41e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CD80—hematologic cancer	1.09e-05	7.4e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PIK3CG—hematologic cancer	1.09e-05	7.39e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—KIT—hematologic cancer	1.09e-05	7.39e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—NRAS—hematologic cancer	1.08e-05	7.38e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—EP300—hematologic cancer	1.08e-05	7.34e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PTPN11—hematologic cancer	1.07e-05	7.26e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—JAK2—hematologic cancer	1.06e-05	7.2e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—MAPK3—hematologic cancer	1.04e-05	7.07e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PIK3CA—hematologic cancer	1.04e-05	7.06e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MDM2—hematologic cancer	1.03e-05	7.03e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CREB1—hematologic cancer	1.03e-05	7.03e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—BRAF—hematologic cancer	1.02e-05	6.94e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CCL2—hematologic cancer	1.01e-05	6.88e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IL6R—hematologic cancer	1.01e-05	6.86e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CREBBP—hematologic cancer	1.01e-05	6.85e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PIK3CB—hematologic cancer	1.01e-05	6.84e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MTOR—hematologic cancer	1.01e-05	6.84e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MAP2K1—hematologic cancer	9.6e-06	6.54e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—HRAS—hematologic cancer	9.6e-06	6.53e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PIK3CD—hematologic cancer	9.54e-06	6.49e-05	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—PIK3CA—hematologic cancer	9.45e-06	6.43e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CDKN1B—hematologic cancer	9.43e-06	6.42e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—KRAS—hematologic cancer	9.34e-06	6.36e-05	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—AKT1—hematologic cancer	9.33e-06	6.35e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CASP3—hematologic cancer	9.24e-06	6.29e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IL2—hematologic cancer	9.23e-06	6.28e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—IL6—hematologic cancer	9.18e-06	6.25e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—FGF2—hematologic cancer	9.13e-06	6.22e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PIK3R1—hematologic cancer	9.01e-06	6.13e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CCND1—hematologic cancer	9e-06	6.12e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—JUN—hematologic cancer	8.98e-06	6.11e-05	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PIK3CA—hematologic cancer	8.95e-06	6.09e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—JAK2—hematologic cancer	8.75e-06	5.96e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CDKN1A—hematologic cancer	8.71e-06	5.93e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PTEN—hematologic cancer	8.69e-06	5.91e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PIK3CA—hematologic cancer	8.58e-06	5.84e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MDM2—hematologic cancer	8.55e-06	5.82e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MAPK8—hematologic cancer	8.5e-06	5.78e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—AKT1—hematologic cancer	8.47e-06	5.77e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PIK3CB—hematologic cancer	8.31e-06	5.66e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MTOR—hematologic cancer	8.31e-06	5.66e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—EP300—hematologic cancer	8.28e-06	5.64e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—SRC—hematologic cancer	8.05e-06	5.48e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PIK3CA—hematologic cancer	7.98e-06	5.43e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—HRAS—hematologic cancer	7.94e-06	5.4e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—VEGFA—hematologic cancer	7.84e-06	5.34e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CDKN1B—hematologic cancer	7.8e-06	5.31e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—STAT3—hematologic cancer	7.77e-06	5.29e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—NRAS—hematologic cancer	7.75e-06	5.27e-05	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—AKT1—hematologic cancer	7.72e-06	5.25e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CASP3—hematologic cancer	7.65e-06	5.2e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IL2—hematologic cancer	7.64e-06	5.2e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—IL6—hematologic cancer	7.6e-06	5.17e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CCND1—hematologic cancer	7.44e-06	5.07e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—JUN—hematologic cancer	7.43e-06	5.06e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MAPK3—hematologic cancer	7.42e-06	5.05e-05	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—AKT1—hematologic cancer	7.31e-06	4.97e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MYC—hematologic cancer	7.22e-06	4.91e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CDKN1A—hematologic cancer	7.2e-06	4.9e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—TGFB1—hematologic cancer	7.2e-06	4.9e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PTEN—hematologic cancer	7.18e-06	4.89e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MAPK8—hematologic cancer	7.03e-06	4.78e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—AKT1—hematologic cancer	7.01e-06	4.77e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—EP300—hematologic cancer	6.85e-06	4.66e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—KRAS—hematologic cancer	6.67e-06	4.54e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—SRC—hematologic cancer	6.66e-06	4.53e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—AKT1—hematologic cancer	6.52e-06	4.44e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—VEGFA—hematologic cancer	6.49e-06	4.42e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—STAT3—hematologic cancer	6.43e-06	4.37e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—NRAS—hematologic cancer	6.41e-06	4.36e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MAPK3—hematologic cancer	6.14e-06	4.18e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PIK3CA—hematologic cancer	6.13e-06	4.17e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MYC—hematologic cancer	5.97e-06	4.06e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—TGFB1—hematologic cancer	5.96e-06	4.05e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—TP53—hematologic cancer	5.93e-06	4.03e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—HRAS—hematologic cancer	5.67e-06	3.86e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—KRAS—hematologic cancer	5.52e-06	3.75e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IL6—hematologic cancer	5.43e-06	3.69e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PIK3CA—hematologic cancer	5.07e-06	3.45e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—AKT1—hematologic cancer	5.01e-06	3.41e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—TP53—hematologic cancer	4.9e-06	3.34e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—HRAS—hematologic cancer	4.69e-06	3.19e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IL6—hematologic cancer	4.49e-06	3.05e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—AKT1—hematologic cancer	4.14e-06	2.82e-05	CbGpPWpGaD
